Molecular Biology Research Communications (MBRC) is an international pree-reviewed journal. It is published quarterly by Shiraz University. The journal welcomes submission of Original articles, Short communications, Invited review articles, and Letters to the Editor which meets the general criteria of significance and scientific excellence in all fields of molecular biology. The journal's short title is Mol. Biol. Res. Commun., which should be used in bibliographies, footnotes and bibliographical references and strips.


Journal Metics (Updated July 10, 2023)

Journal Impact Factor: 1.64

Five year Impact Factor: 1.75   

CiteScore: 3.2

Scimago Journal Rank (SJR): 0.395

Source Normalized Impact per paper (SNIP): 0.675

Scimago Journal & Country Rank

Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

What are some advantages of publishing your work in MBRC?

- Free access for all users worldwide

- First decision within 6-8 weeks of submission

- Prompt and fair peer review from two expert peer reviewers

- Frequent updates on your paper’s status

- Friendly responsive staff

- Increased visibility and readership of your papers

- No page charge



Molecular Biology Research Communications is published quarterly.

Rejection rate: 70%                                                       

Current Issue: Volume 13, Issue 3, 2024 

A survey of resistance mutations to reverse transcriptase inhibitors (RTIs) among HIV-1 patients in northeast of Iran

Pages 117-125


Zahra Mazaheri; Sahar Tahaghoghi-Hajghorbani; Kazem Baesi; Kiarash Ghazvini; Saeid Amel-Jamehdar; Masoud Youssefi

Effects of silymarin as adjuvant drug on serum levels of CTRP3, anti-cyclic citrullinated peptide (CCP), and high-sensitivity C-reactive protein (hs-CRP) in rheumatoid arthritis patients

Pages 137-145


Mohammad Ehsan Elahi; Daniel Elieh-Ali-Komi; Farjam Goudarzi; Ehsan Mohammadi‑Noori; Shirin Assar; Mehrdad Shavandi; Amir Kiani; Homayoin Elahi

Comparison of Mir122 expression in children with biliary atresia and healthy group

Pages 147-154


Nasrin Motazedian; Negar Azarpira; Kimia Falamarzi; Seyed Mohsen Dehghani; Maryam Ataollahi; Elaheh Esfandiari; Mahintaj Dara; Razieh Toobafard; Mehrab Sayadi; Seyed Ali Shekarforoush; Seyed Hossein Owji; Seyed Ali Malekhosseini

The effects of NLRP3 rs10754558 and rs4612666 polymorphisms on preeclampsia susceptibility, onset, and severity: a case-control study and in silico analysis

Pages 165-173


Mahnaz Rezaei; Marzieh Ghasemi; Mohsen Saravani; Rahele Ghasemian-Moghadam; Hossein Shahraki-Ghadimi; Mahtab Norouzi; Saeedeh Salimi

Clinical profile of FTL3-ITD mutation in West Algerian population with acute myeloid leukemia

Pages 175-182


Fatima Zohra Moghtit; Wefa Boughrara; Samia Dorgham; Ilies Koriche; Imene Ouahba; Amina Ammour; Amine Bekadja; Meriem Samia Aberkane